U.S. market Closed. Opens in 11 hours 51 minutes

PCRX | Pacira BioSciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue674.98M666.82M541.53M420.83M421.03M337.28M286.63M276.37M249.00M197.67M85.55M39.08M15.69M14.56M15.01M13.93M
Cost of Revenue241.96M199.29M140.25M117.33M106.71M86.84M87.92M110.10M71.84M77.44M54.77M32.14M16.74M12.28M12.30M17.46M
Gross Profit433.02M467.53M401.28M303.50M314.31M250.43M198.72M166.27M177.16M120.23M30.78M6.95M-1.05M2.29M2.71M-3.54M
Operating Expenses345.70M396.60M268.44M260.80M278.60M232.95M218.78M198.29M167.71M125.39M84.07M56.24M35.03M24.66M31.25M41.83M
Selling, General & Admin269.44M254.52M199.34M193.52M200.78M177.26M161.49M152.61M139.04M106.66M62.51M46.31M20.16MN/AN/AN/A
Research & Development76.26M84.80M55.55M59.42M72.12M55.69M57.29M45.68M28.66M18.73M21.56M9.94M14.87M18.63M26.23M33.21M
Other Operating Expenses-186.00K57.29M13.55M7.87M5.70M-888.00KN/AN/AN/AN/AN/AN/AN/A6.03M5.02M8.61M
Operating Income87.32M60.02M131.06M46.35M38.11M15.91M-24.94M-32.02M9.46M-5.17M-53.29M-49.30M-36.08M-22.37M-28.55M-45.36M
Other Expenses / Income-25.62M-46.72M-74.66M-26.26M-48.86M-2.45M-17.53M-5.82M-7.33M-8.38M-11.06M-2.98M-2.72M-34.00K367.00K-224.00K
Before Tax Income61.70M13.30M56.40M20.09M-10.75M-425.00K-42.47M-37.84M2.12M-13.54M-64.35M-52.28MN/AN/AN/AN/A
Income Tax Expenses19.75M-2.61M14.42M-125.43M268.00K46.00K140.00K105.00K264.00K173.00K-442.00KN/AN/AN/AN/AN/A
Net Income41.95M15.91M41.98M145.52M-11.02M-471.00K-42.61M-37.95M1.86M-13.72M-63.91M-52.28M-43.33M-27.15M-31.71M-41.86M
Interest Expenses23.81M39.98M31.75M25.67M23.63M21.95M16.67M6.45M7.11M8.28M7.25M1.81M4.78M4.89M3.60M3.49M
Basic Shares Outstanding46.22M45.52M44.26M42.67M41.51M40.91M39.81M37.24M36.54M35.30M33.18M30.33M16.44M574.07K573.12K528.36K
Diluted Shares Outstanding51.98M46.54M45.63M43.68M41.51M40.91M39.81M37.24M41.30M35.30M33.18M30.33M16.44M574.07K573.12K528.36K
EBITDA162.90M121.47M144.62M66.86M43.81M23.09M-11.97M-18.48M20.70M4.77M-51.35M-44.83M-38.55M-18.01M-23.67M-34.54M
EBITDA Margin24.13%18.22%26.71%15.89%10.41%6.85%-4.18%-6.69%8.32%2.41%-60.02%-114.69%-245.70%-123.66%-157.75%-248.05%
EBIT85.51M53.28M88.15M45.76M12.88M21.52M-25.80M-31.39M9.23M-5.26M-57.10M-50.47M-38.55M-22.26M-28.10M-38.37M
EBIT Margin12.67%7.99%16.28%10.87%3.06%6.38%-9.00%-11.36%3.71%-2.66%-66.74%-129.14%-245.70%-152.86%-187.29%-275.56%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙